Loading provider…
Loading provider…
Rheumatology Physician in Jacksonville, FL
NPI: 1447240239Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Andy's Phone Numberphone_androidMobile
Get MD Andy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
CA State Medical License
1998
FL State Medical License
1999 - 2026
GA State Medical License
2014 - 2026
KY State Medical License
2014 - 2025
MN State Medical License
1995 - 1998

American Board of Internal Medicine
Rheumatology
St Vincent Hospital
Residency • Internal Medicine
1992 - 1995
Pontifical Bolivarian University
Medical School
Until 1990
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Rheumatology
1995 - 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 173 | 197 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 76 | 76 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 58 | 58 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 37 | 37 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 25 | 25 |
2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Authors: Steven Carsons, William Docken, Mehrdad Maz
Publication Date: 2015-02-20
Authors: Florentina Berianu, Neha Narula, Neha Narula
Journal: Int J Rheum Dis
Publication Date: 2021-04-22
Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage.
Authors: Ronald Butendieck
Publication Date: 2014-07-03
Lead Sponsor: Scleroderma Research Foundation, Inc.
Collaborators: Boehringer Ingelheim, Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: Amlitelimab, DRUG: BI 1015550 (Nerandomilast)
Lead Sponsor: Mayo Clinic
Intervention / Treatment: BIOLOGICAL: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)